Sector Investment 3 Days

Last updated: May 20, 2026, 5:36 PM ET

Healthcare & Life Sciences Private Equity Eir Partners secured a controlling stake in QuartzBio, the Maryland‑based life‑science technology firm founded in 2012, signaling continued appetite for platform investments that can accelerate drug‑discovery pipelines. A few days later, Brightstar Capital committed capital to Simon Eye Holdings, the Wilmington‑based vision‑care provider dating back to 1987, expanding its exposure to integrated optometry services that benefit from aging‑population trends. Together, the deals illustrate how private‑equity sponsors are targeting niche, high‑growth segments of the health sector to capture value beyond traditional pharma buyouts.

Real Estate – Specialty and International Expansion CPP intensified its “last‑mile” push into niche assets by backing Heitman's self‑storage expansion and tapping a student‑housing windfall, underscoring the pension fund’s shift toward higher‑yielding, operationally intensive properties. The same fund broadened its geographic scope when it acquired a minority stake in Blackstone’s French logistics platform Proudreed, marking CPP’s first European co‑investment and highlighting a creative approach to accessing cross‑border logistics growth. Meanwhile, Step Stone’s Jeff Giller warned that lagging performance is prompting scrutiny of manager losses, a reminder that investors remain wary of underperforming assets even as the sector attracts fresh capital.

Industry Talent Moves King Street brought Sujan Patel on board as senior adviser to its European real‑estate business following the departure of co‑head Paul Brennan, a move that reflects the firm’s effort to bolster strategic expertise amid a competitive advisory market. The appointment is part of a broader trend of hiring seasoned professionals to navigate complex cross‑border transactions and to support the expanding portfolio of specialty real‑estate investments.